{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:09:58Z","timestamp":1778998198265,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Agency for Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10787-018-0472-2","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:02:14Z","timestamp":1522807334000},"page":"725-735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Influence of corticosteroid therapy on IL-18 and nitric oxide production during Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Fatmazohra","family":"Djaballah-Ider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Djeraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourad","family":"Chemli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadjiba","family":"Dammene-Debbihe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doulkifly","family":"Lounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houda","family":"Belguendouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanis","family":"Medour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Chaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chafia","family":"Touil-Boukoffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"key":"472_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/0003319715611805","volume":"67","author":"N Acikgoz","year":"2016","unstructured":"Acikgoz N (2016) The neutrophil-lymphocyte ratio and Behcet disease. Angiology 67:297. \n                    https:\/\/doi.org\/10.1177\/0003319715611805","journal-title":"Angiology"},{"key":"472_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcla.21772","volume":"29","author":"ZM Akkurt","year":"2015","unstructured":"Akkurt ZM, Bozkurt M, U\u00e7mak D, Y\u00fcksel H, U\u00e7ak H, Sula B, G\u00fcrsel \u00d6zkurt Z, Yildiz M, Akdeniz D, Arica M (2015) Serum cytokine levels in Beh\u00e7et\u2019s disease. J Clin Lab Anal 29:317\u2013320. \n                    https:\/\/doi.org\/10.1002\/jcla.21772","journal-title":"J Clin Lab Anal"},{"key":"472_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3109\/14397595.2013.879414","volume":"24","author":"E Aktas Cetin","year":"2014","unstructured":"Aktas Cetin E, Cosan F, Cefle A, Deniz G (2014) IL-22-secreting Th22 and IFN-\u03b3-secreting Th17 cells in Beh\u00e7et\u2019s disease. Mod Rheumatol 24:802\u2013807. \n                    https:\/\/doi.org\/10.3109\/14397595.2013.879414","journal-title":"Mod Rheumatol"},{"key":"472_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jfo.2011.05.003","volume":"35","author":"A Arroul-Lammali","year":"2012","unstructured":"Arroul-Lammali A, Djeraba Z, Belkhelfa M, Belguendouz H, Hartani D, Lahlou-Boukoffa OS, Touil-Boukoffa C (2012) Early involvement of nitric oxide in mechanisms of pathogenesis of experimental autoimmune uveitis induced by interphotoreceptor retinoid-binding protein (IRBP). J Fr Ophtalmol 35:251\u2013259. \n                    https:\/\/doi.org\/10.1016\/j.jfo.2011.05.003","journal-title":"J Fr Ophtalmol"},{"key":"472_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0181-5512(08)71433-5","volume":"31","author":"H Belguendouz","year":"2008","unstructured":"Belguendouz H, Messaoudene D, Hartani D, Chachoua L, Ahmedi ML, Lahmar-Belguendouz K, Lahlou-Boukoffa O, Touil-Boukoffa C (2008) Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Beh\u00e7et and idiopathic uveitis. J Fr Ophtalmol 31:387\u2013395","journal-title":"J Fr Ophtalmol"},{"key":"472_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/jir.2010.0148","volume":"31","author":"H Belguendouz","year":"2011","unstructured":"Belguendouz H, Messaoud\u00e8ne D, Lahmar K, Ahmedi L, Medjeber O, Hartani D, Lahlou-Boukoffa O, Touil-Boukoffa C (2011) Interferon-\u03b3 and nitric oxide production during Beh\u00e7et uveitis: immunomodulatory effect of interleukin-10. J Interferon Cytokine Res 31:643\u2013651. \n                    https:\/\/doi.org\/10.1089\/jir.2010.0148","journal-title":"J Interferon Cytokine Res"},{"key":"472_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jfo.2014.10.005","volume":"38","author":"H Belguendouz","year":"2015","unstructured":"Belguendouz H, Messaoudene D, Lahmar-Belguendouz K, Djeraba Z, Otmani F, Terahi M, Tiar M, Hartani D, Lahlou-Boukoffa OS, Touil-Boukoffa C (2015) In vivo and in vitro IL-18 production during uveitis associated with Beh\u00e7et disease: effect of glucocorticoid therapy. J Fr Ophtalmol 38:206\u2013212. \n                    https:\/\/doi.org\/10.1016\/j.jfo.(2014).10.005","journal-title":"J Fr Ophtalmol"},{"key":"472_CR8","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"M Ben Ahmed","year":"2004","unstructured":"Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et\u2019s disease. Arthritis Rheum 50:2291\u20132295. \n                    https:\/\/doi.org\/10.1002\/art.20334","journal-title":"Arthritis Rheum"},{"key":"472_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/rheumatology\/ker345","volume":"51","author":"F Chen","year":"2012","unstructured":"Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, Rosenbaum JT, Yang P (2012) CD40 gene polymorphisms confer risk of Behcet\u2019s disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatol Oxf Engl 51:47\u201351. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/ker345","journal-title":"Rheumatol Oxf Engl"},{"key":"472_CR10","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s Disease (1990) Lancet. Lond Engl 335:1078\u20131080","journal-title":"Lond Engl"},{"key":"472_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","volume":"29","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B (2010) Behcet\u2019s disease: from East to West. Clin Rheumatol 29:823\u2013833. \n                    https:\/\/doi.org\/10.1007\/s10067-010-1430-6","journal-title":"Clin Rheumatol"},{"key":"472_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","volume":"13","author":"F Davatchi","year":"2017","unstructured":"Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M (2017) Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13:57\u201365. \n                    https:\/\/doi.org\/10.1080\/1744666X.2016.1205486","journal-title":"Expert Rev Clin Immunol"},{"key":"472_CR13","first-page":"111","volume":"111","author":"D Mauro Di","year":"2006","unstructured":"Di Mauro D, Bitto L, D\u2019Andrea L, Favaloro A, Giacobbe O, Magaudda L, Rizzo G, Trimarchi F (2006) Behaviour of nitric oxide synthase isoforms in inflammatory human joint diseases: an immunohistochemical study. Ital J Anat Embryol 111:111\u2013123","journal-title":"Ital J Anat Embryol"},{"key":"472_CR14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli H (2006) Autoimmunity vs autoinflammation in Behcet\u2019s disease: do we oversimplify a complex disorder? Rheumatol Oxf Engl 45:1461\u20131465. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kel329","journal-title":"Rheumatol Oxf Engl"},{"key":"472_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/09273948.2012.671882","volume":"20","author":"F Djaballah-Ider","year":"2012","unstructured":"Djaballah-Ider F, Chaib S, Belguendouz H, Talbi D, Touil-Boukoffa C (2012) T cells activation and interferon-\u03b3\/nitric oxide production during Beh\u00e7et disease: a study in Algerian patients. Ocul Immunol Inflamm 20:215\u2013217. \n                    https:\/\/doi.org\/10.3109\/09273948.2012.671882","journal-title":"Ocul Immunol Inflamm"},{"key":"472_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jfo.2010.09.023","volume":"33","author":"Z Djeraba","year":"2010","unstructured":"Djeraba Z, Arroul-Lammali A, Medjeber O, Belguendouz H, Hartani D, Lahlou-Boukoffa O-S, Touil-Boukoffa C (2010) Nitric oxide, biomarker of experimental autoimmune uveitis induced by S antigen. J Fr Ophtalmol 33:693\u2013700. \n                    https:\/\/doi.org\/10.1016\/j.jfo.2010.09.023","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"472_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/08923973.2013.873048","volume":"36","author":"Z Djeraba","year":"2014","unstructured":"Djeraba Z, Boumedine K, Arroul-Lammali A et al (2014) Ex vivo immunomodulatory effect of all- trans-retinoic acid during Beh\u00e7et\u2019s disease: a study in Algerian patients. Immunopharmacol Immunotoxicol 36(1):78\u201386. \n                    https:\/\/doi.org\/10.3109\/08923973.2013.873048","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"472_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/JMDH.S93681","volume":"10","author":"SN Esatoglu","year":"2017","unstructured":"Esatoglu SN, Kutlubay Z, Ucar D, Hatemi I, Uygunoglu U, Siva A, Hatemi G (2017) Beh\u00e7et\u2019s syndrome: providing integrated care. J Multidiscip Healthc 10:309\u2013319. \n                    https:\/\/doi.org\/10.2147\/JMDH.S93681","journal-title":"J Multidiscip Healthc"},{"key":"472_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1067\/mjd.2002.118338","volume":"46","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Beh\u00e7et\u2019s disease: is it a new activity marker? J Am Acad Dermatol 46:50\u201354","journal-title":"J Am Acad Dermatol"},{"key":"472_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1189\/jlb.0602313","volume":"73","author":"JA Gracie","year":"2003","unstructured":"Gracie JA, Robertson SE, McInnes IB (2003) Interleukin-18. J Leukoc Biol 73:213\u2013224","journal-title":"J Leukoc Biol"},{"key":"472_CR21","first-page":"S71","volume":"29","author":"K Hamzaoui","year":"2011","unstructured":"Hamzaoui K (2011) Th17 cells in Beh\u00e7et\u2019s disease: a new immunoregulatory axis. Clin Exp Rheumatol 29:S71\u2013S76","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"472_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F et al (2002) Cytokine profile in Beh\u00e7et\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 31(4):205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"472_CR23","first-page":"S8","volume":"21","author":"A Hamzaoui","year":"2003","unstructured":"Hamzaoui A, Ghra\u00efri H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 21:S8\u201314","journal-title":"Clin Exp Rheumatol"},{"key":"472_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejim.2011.12.011","volume":"23","author":"A Hamzaoui","year":"2012","unstructured":"Hamzaoui A, Houman MH, Massouadia M, Ben Salem T, Khanfir MS, Ben Ghorbel I, Miled M (2012) Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet\u2019s disease in Tunisian patients. Eur J Intern Med 23:347\u2013349. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2011.12.011","journal-title":"Eur J Intern Med"},{"key":"472_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09273948.2015.1136422","volume":"25","author":"Y Horie","year":"2017","unstructured":"Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N (2017) HLA-B51 carriers are susceptible to ocular symptoms of beh\u00e7et disease and the association between the two becomes stronger towards the East along the silk road: a literature survey. Ocul Immunol Inflamm 25:37\u201340. \n                    https:\/\/doi.org\/10.3109\/09273948.2015.1136422","journal-title":"Ocul Immunol Inflamm"},{"key":"472_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00296-014-3171-3","volume":"35","author":"EE \u0130nal","year":"2015","unstructured":"\u0130nal EE, R\u00fcstemo\u011flu A, \u0130nan\u0131r A, Ekinci D, G\u00fcl \u00dc, Yi\u011fit S, Ate\u015f \u00d6 (2015) Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Beh\u00e7et\u2019s disease. Rheumatol Int 35:837\u2013843. \n                    https:\/\/doi.org\/10.1007\/s00296-014-3171-3","journal-title":"Rheumatol Int"},{"key":"472_CR27","first-page":"559","volume":"48","author":"Y \u0130\u015fcan","year":"2012","unstructured":"\u0130\u015fcan Y, Yi\u011fit U, Tu\u011fcu B\u00c7, Erdo\u011fan M, Erdo\u011fan DA, \u00d6ner V, Ta\u015f M, \u00d6zyazgan Y (2012) Tear nitric oxide levels in Beh\u00e7et\u2019s disease. Med Kaunas Lith 48:559\u2013562","journal-title":"Med Kaunas Lith"},{"issue":"11","key":"472_CR28","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10067-010-1491-6","volume":"29","author":"VD Kapsimali","year":"2010","unstructured":"Kapsimali VD, Kanakis MA, Vaiopoulos GA et al (2010) Etiopathogenesis of Beh\u00e7et\u2019s disease with emphasis on the role of immunological aberrations. Clin Rheumatol 29(11):1211\u20131216. \n                    https:\/\/doi.org\/10.1007\/s10067-010-1491-6","journal-title":"Clin Rheumatol"},{"key":"472_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/bjo.87.10.1264","volume":"87","author":"B Li","year":"2003","unstructured":"Li B, Yang P, Zhou H, Zhang Z, Xie C, Lin X, Huang X, Kijlstra A (2003) T-bet expression is up regulated in active Beh\u00e7et\u2019s disease. Br J Ophthalmol 87:1264\u20131267","journal-title":"Br J Ophthalmol"},{"key":"472_CR30","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1097\/MD.0000000000001858","volume":"94","author":"G Lopalco","year":"2015","unstructured":"Lopalco G, Lucherini OM, Vitale A, Talarico R, Lopalco A, Galeazzi M, Lapadula G, Cantarini L, Iannone F (2015) Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for Behcet\u2019s disease. Medicine (Baltimore) 94:e1858. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000001858","journal-title":"Medicine (Baltimore)"},{"key":"472_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00200","author":"G Lopalco","year":"2017","unstructured":"Lopalco G, Lucherini OM, Lopalco A, Venerito V, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Cantarini L, Iannone F (2017) Cytokine signatures in mucocutaneous and ocular Beh\u00e7et\u2019s disease. Front Immunol. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00200","journal-title":"Front Immunol"},{"key":"472_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00296-005-0029-8","volume":"26","author":"U Musabak","year":"2006","unstructured":"Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A (2006) Serum interleukin-18 levels in patients with Beh\u00e7et\u2019s disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 26:545\u2013550. \n                    https:\/\/doi.org\/10.1007\/s00296-005-0029-8","journal-title":"Rheumatol Int"},{"key":"472_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7861\/clinmedicine.17-1-71","volume":"17","author":"JR Nair","year":"2017","unstructured":"Nair JR, Moots RJ (2017) Behcet\u2019s disease. Clin Med Lond Engl 17:71\u201377. \n                    https:\/\/doi.org\/10.7861\/clinmedicine.17-1-71","journal-title":"Clin Med Lond Engl"},{"key":"472_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H et al (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423\u2013474. \n                    https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.423","journal-title":"Annu Rev Immunol"},{"key":"472_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2249.2008.03626.x","volume":"152","author":"K Nara","year":"2008","unstructured":"Nara K, Kurokawa MS, Chiba S, Yoshikawa H, Tsukikawa S, Matsuda T, Suzuki N (2008) Involvement of innate immunity in the pathogenesis of intestinal Beh\u00e7et\u2019s disease. Clin Exp Immunol 152:245\u2013251. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03626.x","journal-title":"Clin Exp Immunol"},{"key":"472_CR36","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.intimp.2013.07.017","volume":"17","author":"FS Neves","year":"2013","unstructured":"Neves FS, Spiller F (2013) Possible mechanisms of neutrophil activation in Beh\u00e7et\u2019s disease. Int Immunopharmacol 17:1206\u20131210. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2013.07.017","journal-title":"Int Immunopharmacol"},{"key":"472_CR37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10067-009-1261-5","volume":"28","author":"FS Neves","year":"2009","unstructured":"Neves FS, Carrasco S, Goldenstein-Schainberg C, Gon\u00e7alves CR, de Mello SBV (2009) Neutrophil hyperchemotaxis in Beh\u00e7et\u2019s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clin Rheumatol 28:1403\u20131410. \n                    https:\/\/doi.org\/10.1007\/s10067-009-1261-5","journal-title":"Clin Rheumatol"},{"key":"472_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.niox.2005.11.001","volume":"14","author":"JC Niles","year":"2006","unstructured":"Niles JC, Wishnok JS, Tannenbaum SR (2006) Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide Biol Chem 14:109\u2013121. \n                    https:\/\/doi.org\/10.1016\/j.niox.2005.11.001","journal-title":"Nitric Oxide Biol Chem"},{"key":"472_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/RHU.0000000000000424","volume":"22","author":"AG Palestine","year":"2016","unstructured":"Palestine AG, Kolfenbach JR, Ozzello DJ (2016) Rheumatologists and ophthalmologists differ in treatment decisions for ocular Beh\u00e7et disease. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 22:316\u2013319. \n                    https:\/\/doi.org\/10.1097\/RHU.0000000000000424","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"472_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2164-8-271","volume":"8","author":"D Rico","year":"2007","unstructured":"Rico D, Vaquerizas JM, Dopazo H et al (2007) Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences. BMC Genomics 8:271. \n                    https:\/\/doi.org\/10.1186\/1471-2164-8-271","journal-title":"BMC Genomics"},{"key":"472_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1468-3083.2003.t01-1-00574.x","volume":"17","author":"B Sancak","year":"2003","unstructured":"Sancak B, Onder M, Oztas MO, Bukan N, G\u00fcrer MA (2003) Nitric oxide levels in Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol JEADV 17:7\u20139","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"6684","key":"472_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/31002","volume":"393","author":"SP Schoenberger","year":"1998","unstructured":"Schoenberger SP, Toes RE, van der Voort EI et al (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393(6684):480\u2013483. \n                    https:\/\/doi.org\/10.1038\/31002","journal-title":"Nature"},{"key":"472_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2249.2011.04543.x","volume":"168","author":"J Shimizu","year":"2012","unstructured":"Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N (2012) Excessive CD4+\u2009T cells co-expressing interleukin-17 and interferon-\u03b3 in patients with Beh\u00e7et\u2019s disease. Clin Exp Immunol 168:68\u201374. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04543.x","journal-title":"Clin Exp Immunol"},{"key":"472_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/09273948.2016.1158276","volume":"25","author":"M Takeuchi","year":"2017","unstructured":"Takeuchi M, Karasawa Y, Harimoto K, Tanaka A, Shibata M, Sato T, Caspi RR, Ito M (2017) Analysis of Th Cell-related cytokine production in Beh\u00e7et disease patients with uveitis before and after infliximab treatment. Ocul Immunol Inflamm 25:52\u201361. \n                    https:\/\/doi.org\/10.3109\/09273948.2016.1158276","journal-title":"Ocul Immunol Inflamm"},{"key":"472_CR45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/cei.12193","volume":"174","author":"H Tanaka","year":"2013","unstructured":"Tanaka H, Yang G-X, Iwakoshi N, Knechtle SJ, Kawata K, Tsuneyama K, Leung P, Coppel RL, Ansari AA, Joh T, Bowlus C, Gershwin ME (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 174:364\u2013371. \n                    https:\/\/doi.org\/10.1111\/cei.12193","journal-title":"Clin Exp Immunol"},{"key":"472_CR46","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-008-0963-4","volume":"27","author":"S Taysi","year":"2008","unstructured":"Taysi S, Sari RA, Dursun H, Yilmaz A, Keles M, Cayir K, Akyuz M, Uyanik A, Guvenc A (2008) Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet\u2019s disease. Clin Rheumatol 27:1529\u20131534. \n                    https:\/\/doi.org\/10.1007\/s10067-008-0963-4","journal-title":"Clin Rheumatol"},{"key":"472_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0300-9084(99)80027-3","volume":"80","author":"C Touil-Boukoffa","year":"1998","unstructured":"Touil-Boukoffa C, Bauvois B, Sanc\u00e9au J, Hamrioui B, Wietzerbin J (1998) Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie 80:739\u2013744","journal-title":"Biochimie"},{"issue":"1","key":"472_CR48","first-page":"22","volume":"71","author":"J Tridetti","year":"2016","unstructured":"Tridetti J, Benoit A, Borgoens P et al (2016) Cardiovascular involvements in Beh\u00e7et\u2019s disease: \u201cANGIO-BEH\u00c7ET\u201d. Rev Med Liege 71(1):22\u201327","journal-title":"Rev Med Liege"},{"key":"472_CR49","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1073\/pnas.0712003105","volume":"105","author":"MD Trottier","year":"2008","unstructured":"Trottier MD, Newsted MM, King LE, Fraker PJ (2008) Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function. Proc Natl Acad Sci USA 105:2028\u20132033. \n                    https:\/\/doi.org\/10.1073\/pnas.0712003105","journal-title":"Proc Natl Acad Sci USA"},{"key":"472_CR50","first-page":"12","volume":"2","author":"H Wang","year":"2017","unstructured":"Wang H, Yang P-Z, Peng X-Y, Zhao M, Zhou H-Y, Huang X-K (2017) An increased expression of CD40\/CD40L costimulatory molecules in erythema nodosum of patients with Beh\u00e7et\u2019s disease. Int J Ophthalmol 2:12\u201315","journal-title":"Int J Ophthalmol"},{"key":"472_CR51","first-page":"322","volume":"19","author":"L Xue","year":"2015","unstructured":"Xue L, Zhu X-H, Yang X-F, Bao X-C, Gao X-Q, Qiu Y-H, Wu Z, Ji X-P, Li H-W (2015) Effect of pioglitazone combined with simvastatin on the CD40-CD40 ligand system in rabbits with atherosclerosis. Eur Rev Med Pharmacol Sci 19:322\u2013327","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"472_CR52","doi-asserted-by":"crossref","unstructured":"Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H (2001) Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 44:275\u2013285. https:\/\/doi.org\/10.1002\/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B","DOI":"10.1002\/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B"},{"key":"472_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","volume":"7","author":"MJ Zeidan","year":"2016","unstructured":"Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P (2016) Beh\u00e7et\u2019s disease physiopathology: a contemporary review. Auto-Immun Highlights 7:4. \n                    https:\/\/doi.org\/10.1007\/s13317-016-0074-1","journal-title":"Auto-Immun Highlights"},{"key":"472_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-017-0644-y","author":"S-H Zhang","year":"2017","unstructured":"Zhang S-H, Zhang F-X (2017) Behcet\u2019s disease with recurrent thoracic aortic aneurysm combined with femoral artery aneurysm: a case report and literature review. J Cardiothorac Surg. \n                    https:\/\/doi.org\/10.1186\/s13019-017-0644-y","journal-title":"J Cardiothorac Surg"},{"issue":"10","key":"472_CR55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","volume":"11","author":"ZY Zhou","year":"2012","unstructured":"Zhou ZY, Chen SL, Shen N et al (2012) Cytokines and Behcet\u2019s disease. Autoimmun Rev 11(10):699\u2013704. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2011.12.005","journal-title":"Autoimmun Rev"},{"key":"472_CR56","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1074\/jbc.M611040200","volume":"282","author":"E Ziesche","year":"2007","unstructured":"Ziesche E, Bachmann M, Kleinert H, Pfeilschifter J, M\u00fchl H (2007) The interleukin-22\/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 282:16006\u201316015. \n                    https:\/\/doi.org\/10.1074\/jbc.M611040200","journal-title":"J Biol Chem"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-018-0472-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0472-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-018-0472-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:39:00Z","timestamp":1553819940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-018-0472-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1007\/s10787-018-0472-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"assertion":[{"value":"21 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no conflicts of interest with regard to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript was approved by all co-authors. The local ethics committee \u201cAlgerian National Agency for Research in Health Sciences, ATRSS ex-ANDRS\u201d in compliance with Helsinki declaration has approved our study (Code number 43-ANDRS-2011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}